Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.
Tokuyasu D, Suzuki S, Uzawa A, Nagane Y, Masuda M, Konno S, Kubota T, Samukawa M, Sugimoto T, Ishizuchi K, Oyama M, Yasuda M, Akamine H, Onishi Y, Suzuki Y, Kawaguchi N, Minami N, Kimura T, Takahashi MP, Murai H, Utsugisawa K.
Tokuyasu D, et al. Among authors: kubota t.
Ann Clin Transl Neurol. 2024 Apr 4. doi: 10.1002/acn3.52051. Online ahead of print.
Ann Clin Transl Neurol. 2024.
PMID: 38572524
Free article.